Catalog No.
DVV02802
Expression system
Mammalian Cells
Species reactivity
HRSV-A
Host species
Humanized
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
Concentration
3.67 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03420
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
MEDI-8897, MEDI8897, CAS: 1989556-22-0
Clone ID
Nirsevimab
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants, PMID: 32726528
Single-dose nirsevimab prevents RSV infection, PMID: 33342497
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants, PMID: 32730699
Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper, PMID: 34456918
Global molecular diversity of RSV - the "INFORM RSV" study, PMID: 32591017
Nirsevimab reduces medically attended RSV-associated lower respiratory tract infection and hospitalisations in healthy pre-term infants, PMID: 33597216
Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies, PMID: 32759319
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus, PMID: 34446722
For research use only. Not for human or drug use.
